The content on this site is intended for healthcare professionals only
Prof Monique Roobol speaks to ecancer at EMUC 2019 in Vienna about active surveillance for men with low risk prostate cancer.
She discusses the PRIAS study, which studies active surveillance of men with low risk prostate cancer in order to understand better when to switch to active treatment.
Hopefully this will reduce the occurrence of over-diagnosis.
BRCA1/BRCA2 germline mutations in patients with breast/ovarian cancer
Customised colorectal cancer early diagnosis programme can identify advanced adenomas and early-stage cancer
Mobile prostate cancer screening clinic can help address barriers to serving high-risk communities
New classification for identifying HR myeloma based on cytogenetic abnormalities
Tele-mentoring: Impact of project ECHO
Powering equity in cancer care through digital health
Best practice in HRRm testing in patients with metastatic prostate cancer
Genomic testing: Awareness and effective communication between healthcare professionals and patients
OncoAlert Round Up for September 15-21, 2023
